Massachusetts General Hospital (Data Collection Only) — Boston, Massachusetts

Public research footprint of Massachusetts General Hospital (Data Collection Only), compiled from the ClinicalTrials.gov public registry.

5,764

Registered studies

1,543

Active

769

Recruiting now

3,151

Completed

819

Stopped or withdrawn

Most-studied conditions

PDAC - Pancreatic Ductal Adenocarcinoma · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative · Myelodysplastic Syndrome With Excess Blasts-1 · Metastatic Non-Cutaneous Melanoma

Recently updated registry entries

NCT06690398 — Multicenter Study of Lumateperone for the Treatment of Irritability Associated With… (Recruiting)
NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Massachusetts General Hospital (Data Collection Only)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.